Exosomes: Novel effectors of human platelet lysate activity

European Cells and Materials

Volumn 28, Issue , 2014, Pages 137-151

  Torreggiani, E ^a   Perut, F ^a   Roncuzzi, L ^a   Zini, N ^a,b   Baglio S R ^a   Baldini, N ^a,c  

^a RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Bone marrow stromal cells; Cell free regeneration therapies; Exosomes; Growth factors; Nanodelivery system; Platelet lysate; Platelet richplasma; RNA

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN HYDROLYSATE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN; CELL EXTRACT; MICRORNA; PLATELET DERIVED GROWTH FACTOR B; PLATELET-DERIVED GROWTH FACTOR BB; VASCULOTROPIN A;

ARTICLE; BONE DEVELOPMENT; BONE MARROW STROMA CELL; BONE REGENERATION; CELL CULTURE; CELL DIFFERENTIATION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL REGENERATION; CELL VACUOLE; CHEMOTAXIS; CONTROLLED STUDY; DEGRANULATION; ELECTRON MICROSCOPY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXOSOME; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; OSTEOBLAST; PROTEIN EXPRESSION; RNA ISOLATION; THROMBOCYTE; THROMBOCYTE RICH PLASMA; ULTRACENTRIFUGATION; WESTERN BLOTTING; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; PHYSIOLOGY; ULTRASTRUCTURE;

BLOOD PLATELETS; CELL DIFFERENTIATION; CELL EXTRACTS; CELL PROLIFERATION; EXOSOMES; FIBROBLAST GROWTH FACTOR 2; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; PROTO-ONCOGENE PROTEINS C-SIS; TRANSFORMING GROWTH FACTOR BETA1; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907818281     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v028a11     Document Type: Article

References (123)

1. Baglio SR, Pegtel DM, Baldini N (2012) Mesenchymal stem cells secreted vesicles provide novel opportunities in (stem) cell-free therapy. Front Physiol 3: 359.
2. Balaj L, Lessard R, Dai L, Cho YJ, Pomeroy SL, Breakefield XO, Skog J (2011) Tumor microvescicles contain retrotrasposon elements and amplified oncogene sequences. Nat Commun 2: 180.
3. Banward JC, Asher MA, Hassanein RS (1995) Iliac crest bone graft harvest donor site morbidity. Spine 20: 1055-1060.
4. Bard MP, Hegmans JP, Hemmes A, Luider TM, Willemsen R, Severijnen LA, van Meerbeeck JP, Burgers SA, Hoogsteden HC, Lambrecht BN (2004) Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol 31: 114-121.
5. Bieback K, Hecker A, Kocaömer A, Lannert H, Schallmoser K, Strunk D, Klüter H (2009) Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells 27: 2331-2341.
6. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D (2005) Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 67: 30-38.
7. Brill A, Elinav H, Varon D (2004) Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 63: 226-235.
8. Bu N, Li QL, Feng Q, Sun BZ (2006) Immune protection effect of exosomes against attack of L1210 tumor cells. Leuk Limphoma 47: 913-918.
9. Caby MP, Lankar D, Vincendeau-Scherrer C, Raposo G, Bonnerot C (2005) Exosomal-like vesicles are present in human blood plasma. Int Immunol 17: 879-887.
10. Camacho L, Guerrero P, Marchetti D (2013) MicroRNA and Protein Profiling of Brain Metastasis Competent Cell- Derived Exosomes. PLoS One 8: e73790.
11. Caplan AI and Correa D (2011) PDGF in bone formation and regeneration: new insights into a novel mechanism involving MSCs. J Orthop Res 29: 1795-1803.
12. Carter MJ, Fylling CP, Parnell LK (2011) Use of platelet rich plasma gel on wound healing: a systematic review and meta-analysis. Eplasty 11: 382-410.
13. Chen B, Sun HH, Wang HG, Kong H, Chen FM, Tu Q (2012) The effects of human platelet lysate on dental pulp stem cells derived from impacted human third molars. Biomaterials 33: 5023-5035.
14. Cho JW, Kim SA, Lee KS (2012) Platelet-rich plasma induces increased expression of G1 cell cycle regulators, type I collagen, and matrix metalloproteinase-1 in human skin fibroblasts. Int J Mol Med 29: 32-36.
15. Clayton A, Mitchell JP, Court J, Linnane S, Mason MD, Tabi Z (2008) Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol 180: 7249-7258.
16. Clayton A, Mitchell JP, Court J, Mason MD, Tabi Z (2007) Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res 67: 7458-7466.
17. Dallari D, Savarino L, Stagni C, Cenni E, Cenacchi A, Fornasari PM, Albissini U, Rimondi E, Baldini N, Giunti A (2007) Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 89: 2413-2420.
18. De Jong OG, Verhaar MC, Chen Y, Vader P, Gremmels H, Posthuma G, Schiffelers RM, Gucek M, van Balkom BWM (2012) Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes. J Extracell Vescicles 1: 10.3402/jev.v1i0.18396.
19. Eckardt H, Ding M, Lind M, Hansen ES, Christensen KS, Hvid I (2005) Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87: 1434-1438.
20. Fekete N, Gadelorge M, Fürst D, Maurer C, Dausend J, Fleury-Cappellesso S, Mailänder V, Lotfi R, Ignatius A, Sensebé L, Bourin P, Schrezenmeier H, Rojewski MT (2012) Platelet lysate from whole blood-derived pooled platelet concentrates and apheresis-derived platelet concentrates for the isolation and expansion of human bone marrow mesenchymal stromal cells: production process, content and identification of active components. Cytotherapy 14: 540-554.
21. Fennis JP, Stoelinga PJ, Jansen JA (2002) Mandibular reconstruction: a clinical and radiographic animal study on the use of autogenous scaffolds and platelet-rich plasma. Int J Oral Maxillofac Surg 31: 281-286.
22. Fleming JE, Cornell CN, Muschler GF (2000) Bone cells and matrices in orthopaedic tissue engineering. Orthop Clin North Am 31: 357-374.
23. Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA (2009) Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med 37: 2259-2272.
24. Franchini M, Dupplicato P, Ferro I, De Gironcoli M, Aldegheri R (2005) Efficacy of platelet gel in reconstructive bone surgery. Orthopedics 28: 161- 163.
25. Froum SJ, Wallace SS, Tarnow DP, Cho SC (2002) Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Restorative Dent 22: 45-53.
26. Gandhi A, Bibbo C, Pinzur M, Lin SS (2005) The role of platelet-rich plasma in foot and ankle surgery. Foot Ankle Clin 10: 621-637.
27. Gerber HP, Vu TH, Ryan AM, Kowalski J, Werb Z, Ferrara N (1999) VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat Med 5: 623-628.
28. Gonzales PA, Zhou H, Pisitkun T, Wang NS; Star RA, Knepper MA, Yuen PS (2010) Isolation and purification of exosomes in urine. Methods Mol Biol 641: 89-99.
29. Gould SJ, Booth AM, Hildretch JEK (2003) The Trojan exosome hyphotesis. Proc Natl Acad Sci USA 100: 10592- 10597.
30. Govidasami V, Ronald VS, Abdullah AN, Ganesan Nathan KR, Aziz ZA, Abdullah M, Zain RB, Kasim NH, Musa S, Bhonde RR (2011) Human platelet lysate permits scale-up of dental pulp stromal cells for clinical applications. Cytotherapy 13: 1221-1233.
31. Graham S, Leonidou A, Lester M, Heliotis M, Mantalaris A, Tsiridis E (2009) Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing. Expert Opin Investig Drugs 18: 1633- 1654.
32. Granchi D, Devescovi V, Pratelli L, Verri E, Magnani M, Donzelli O, Baldini N (2013) Serum levels of fibroblast growth factor 2 in children with orthopaedic diseases: potential role in predicting bone healing. J Orthop Res 31: 249-256.
33. Grant R, Ansa-Addo E, Stratton D, Antwi-Baffour S, Jorfi S, Kholia S, Krige L, Lange S, Inal J (2011) J Immunol Methods 371: 143-151.
34. Hall MP, Ward JP, Cardone DA (2013) Platelet rich placebo? Evidence for platelet rich plasma in the treatment of tendinopathy and augmentation of tendon repair. Bull Hosp Jt Dis 71: 54-59.
35. Hee HT, Majd ME, Holt RT, Myers L (2003) Do autologous growth factors enhance transforaminal lumbar interbody fusion? Eur Spine J 12: 400-407.
36. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vescicles: microvescicles by surface shedding and exosomes derived from exocytosis of multivescicular bodies and alpha-granules. Blood 17: 578-584.
37. Hemeda H, Giebel B, Wagner W (2014) Evaluation of human platelet lysate versus fetal bovine serum for culture of mesenchymal stromal cells. Cytotherapy 16: 170-80.
38. Italiano JR Jr, Mairuhu AT, Flaumenhaft R (2010) Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol 94: 3791-3799.
39. Jonsdottir-Buch SM, Lieder R, Sigurjonsson OE (2013) Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells. PloS One 8: e68984.
40. Kawaguchi H, Oka H, Jingushi S, Izumi T, Fukunaga M, Sato K, Matsushita T, Nakamura K; TESK Group (2010) A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res 25: 2735-2743.
41. Keller S, Ridinger J, Rupp AK, Janssen JW, Altevogt P (2011) Body fluid derived exosomes as a novel template for clinical diagnostics. J Transl Med 9: 86.
42. Kempen DH, Creemers LB, Alblas J, Lu L, Verbout AJ, Yaszemski MJ, Dhert WJ (2010) Growth factor interactions in bone regeneration. Tissue Eng Part B Rev 16: 551-566.
43. Kharaziha P, Ceder S, Li Q, Panaretakis T (2012) Tumor cell-derived exosomes: a message in a bottle. Biochim Biophys Acta 1826: 103-111.
44. Kilian O, Flesch I, Wenisch S, Taborski B, Jork A, Schnettler R, Jonuleit T (2004) Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. Eur J Med Res 9: 337-344.
45. Lai RC, Arslan F, Lee MM, Sze NS, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM, Pasterkamp G, de Kleijn DP, Lim SK (2010) Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res 4: 214-222.
46. Lai RC, Chen TS, Lim SK (2011) Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease. Regen Med 6: 481-492.
47. Lane JG, Healey RM, Chase DC, Amiel D (2013) Use of platelet-rich plasma to enhance tendon function and cellularity. Am J Orthop 42: 209-214.
48. Lasser JG, Alikhani VS, Ekstrom K, Eldh M, Paredes PT, Bossios A, Sjöstrand M, Gabrielsson S, Lötvall J, Valadi H (2011) Human saliva, plasma and breast milk exosomes contain RNA: uptake by macrophages. J Transl Med 9: 9.
49. Lee JC, Min HJ, Park HJ, Lee S, Seong SC, Lee MC (2013) Synovial membrane-derived mesenchymal stem cells supported by platelet-rich plasma can repair osteochondral defects in a rabbit model. Arthroscopy 29: 1034-1046.
50. Lee KS (2013) Platelet-rich plasma injection. Semin Musculoskelet Radiol 17: 91-98.
51. Lehmann BD, Paine MS, Brooks AM, McCubrey JA, Renegar RH, Wang R, Terrian DM (2008) Senescence-associated exosome release from human prostate cancer cells. Cancer Res 68: 7864-7871.
52. Liao HT, Marra K, Rubin PJ (2014) Application of platelet-rich plasma and platelet-rich fibrin in fat graftin: basic science and literature review. Tissue Eng Part B Rev 20: 267-276.
53. Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A: 1032-1044.
54. Lind, M (1998) Growth factor stimulation of bone healing. Effects on osteoblasts, osteomies, and implants fixation. Acta Orthop Scand Suppl 283: 2-37.
55. Lohmann M, Walenda G, Hemeda H, Joussen S, Drescher W, Jockenhoevel S, Hutschenreuter S, Zenke M, Wagner W (2012) Donor age of human platelet lysate affects proliferation and differentiation of mesenchymal stem cells. PloS One 7: e37839.
56. Lv LL, Cao YH, Ni HF, Xu M, Liu D, Liu H, Chen PS, Liu BC (2013) MicroRNA-29c in urinary exosome/ microvesicle as a biomarker of renal fibrosis. Am J Physiol Renal Physiol 305: F1220-1227.
57. Malhotra A, Pelletier MH, Yu Y, Walsh WR (2013) can platelet-rich plasma (PRP) improve bone haeling? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg 133: 153-165.
58. Malik A, Shaari R, Rahman SA, Aljuboori MJ (2012) Influence of platelet-rich plasma on dental implants. Osseointegration in well-controlled diabetic patients. Dent Implantol Update 23: 89-96.
59. Marx RE (2004) Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62: 489.
60. Mathivanan S, Ji H, Simpson RJ (2010) Exosomes: extracellular organelles important in intercellular communication. J Proteomics 73: 1907-1920.
61. Mineo M, Garfield SH, Taverna S, Flugy A, De Leo G, Alessandro R, Kohn EC (2012) Exosomes released by K562 chronic myeloid leukemia cells promote angiogenesis in a src-dependent fashion. Angiogenesis 15: 33-45.
62. Moldovan L, Batte K, Wang Y, Wisler J, Piper M (2013) Analyzing the circulating microRNAs in exosomes/ extracellular vesicles from serum or plasma by qRT-PCR. Methods Mol Biol 1024: 129-145.
63. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, Doetschman T, Coffin JD, Hurley MM (2000) Disruption of the fibroblast growth factor- 2 gene results in decreased bone mass and bone formation. J Clin Invest 105: 1085-1093.
64. Moore DC, Ehrlich MG, McAllister SC, Machan JT, Hart CE, Voigt C, Lesieur-Brooks AM, Weber EW (2009) Recombinant human platelet-derived growth factor-BB augmentation of new-bone formation in a rat model of distraction osteogenesis. J Bone Joint Surg Am 91: 1973- 1984.
65. Nguyen DG, Booth A, Gould SJ, Hildreth JE (2003) Evidence that HIV budding in primary macrophages occurs through the exosome release pathway. J Biol Chem 278: 52347-52354.
66. Nguyen RT, Borg-Stein J, McInnis K (2011) Applications of platelet-rich plasma in musculoskeletal and sports medicine: an evidence-based approach. PM R 3: 226-250.
67. O'Brien K, Rani S, Corcoran C, Wallace R, Hughes L, Friel AM, MsDonnell S, Crown J, Radomski MW, O'Driscoll L (2013) Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells. Eur J Cancer 49: 1845-1859.
68. Passaretti F, Tia M, D'Esposito V, Pascale MD, Corso MD, Sepulveres R, Liguoro D, Valentino R, Beguinot F, Formisano P, Sammartino G (2014) Growth-promoting action and growth factor release by different platelet derivates. Platelets 25: 252-256
69. Perut F, Filardo G, Mariani E, Cenacchi A, Pratelli L, Devescovi V, Kon E, Marcacci M, Facchini A, Baldini N, Granchi D (2013) Preparation methods and growth factor content of platelet concentrate influence the osteogenic differentiation of bone marrow stromal cells. Cytotherapy 15: 830-839.
70. Pietramaggiori G, Scherer SS, Mathews JC, Alperovich M, Yang HJ, Neuwalder J, Czeczuga JM, Chan RK, Wagner CT, Orgill DP (2008) Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16: 218-225.
71. Plé H, Landry P, Benham A, Coarfa C, Gunaratne PH, Provost P (2012) The repertoire and features of human platelet microRNAs. PloS One 12:e50746. doi: 10.1371/ journal.pone.0050746.
72. Presta M, Dell'Era P, Mitola S, Moroni E, Ronca R, Rusnati M (2006) Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16: 159-178.
73. Raposo G, Nijman HW, Stoorvogel W, Liejendekker R, Harding CV, Melief CJ, Geuze HJ (1996) B lymphocytes secrete antigen-presenting vesicles. J Exp Med 183: 1161- 1172.
74. Record M, Subra C, Silvente-Poirot S, Poirot M (2011) Exosomes as intercellular signalosomes and pharmacological effectors. Biochem Pharmacol 81: 1171- 1182.
75. Rendu F, Brohard-Bohn B (2001) The platelet release reaction: granules constituents, secretion and functions. Platelets 12: 261-273.
76. Rhee JS, Black M, Schubert U, Fischer S, Morgenstern E, Hammes HP, Preissner KT (2004) The functional role of blood platelet components in angiogenesis. Thromb Haemost 92: 394-402.
77. Ritchie AJ, Crawford DM, Ferguson DJ, Burthem J, Roberts DJ (2013) Normal prion protein is expressed on exosomes isolated from human plasma. Br J Haematol 163: 678-80.
78. Roccaro AM, Sacco A, Maiso P, Azab AK, Tai YT, Reagan M, Azab F, Flores LM, Campigotto F, Weller E, Anderson KC, Scadden DT, Ghobrial IM (2013) BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123: 1542- 1555.
79. Ruggiu A, Ulivi V, Sanguineti F, Cancedda R, Descalzi F (2013) The effect of Platelet Lysate on osteoblast proliferation with a transient increase of the inflammatory response in bone regeneration. Biomaterials 34: 9318- 9330.
80. Sahoo S, Klychko E, Thorne T, Misener S, Schultz KM, Millay M, Ito A, Liu T, Kamide C, Agrawal H, Perlman H, Qin G, Kishore R, Losordo DW (2011) Exosomes from human CD34(+) stem cells mediate their proangiogenic paracrine activity. Circ Res 109: 724-728.
81. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, Rice GE (2013) Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PloS One 8: e68451.
82. Sanchez M, Azofra J, Anitua E, Andia I, Padilla S, Santisteban J, Mujika I (2003) Plasma rich in growth factors to treat an articular cartilage avulsion: a case report. Med Sci Sports Exerc 35: 1648-1652.
83. Sanderson MP, Keller S, Alonso A, Riedle S, Dempsey PJ, Altevogt P (2008) Generation of novel, secreted epidermal growth factor receptor (EGFR/ErbB1) isoforms via metalloprotease dependent ectodomain shedding and exosome secretion. J Cell Biochem 103:1783-1797.
84. Savarino L, Cenni E, Tarabusi C, Dallari D, Stagni C, Cenacchi A, Fornasari PM, Giunti A, Baldini N (2006) Evaluation of bone healing enhancement by lyophilized bone grafts supplemented with platelet gel: a standardized methodology in patients with tibial osteotomy for genu varus. J Biomed Mater Res B Appl Biomater 76: 364-372.
85. Schallmoser K, Bartmann C, Rohde E, Reinisch A, Kashofer K, Stadelmeyer E, Drexler C, Lanzer G, Linkesch W, Strunk D (2007) Human platelet lysate can replace fetal bovine serum for clinical-scale expansion of functional mesenchymal stromal cells. Transfusion 47: 1436-1446.
86. Schallmoser K, Rohde E Reinisch A Bartmann C, Thaler D, Drexler C, Obenauf AC, Lanzer G, Linkesch W, Strunk D (2008) Rapid large-scale expansion of functional mesenchymal stem cells from unmanipulated bone marrow without animal serum. Tissue Eng Part C Methods 14: 185-196.
87. Schliephake H (2002) Bone growth factors in maxillofacial skeletal reconstruction. Int J Oral Maxillofac Surg 31: 469-484.
88. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichs C, Klinz FJ, Brixius K, Arnhold S, Desal B, Mehlhorn U, Schwinger RHG, Staib P, Addicks K, Bloch W (2006) Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells 24:1750- 1758.
89. Schneider A, Simons M (2013) Exosomes: vescicular carriers for intercellular communication in neurodegenerative disorders. Cell Tissue Res 352: 33-47.
90. Seelenmeyer C, Stegmayer C, Nickel W (2008) Unconventional secretion of fibroblast growth factor 2 and galectin-1 does not require shedding of plasma membrane-derived vesicles. FEBS Lett 582: 1362-1368.
91. Silverman JM, Reiner NE (2011) Exosomes and other microvescicles in infection biology: organelles with unanticipated phenotypes. Cell Microbiol 13: 1-9.
92. Slater M, Patava J, Kingham K, Mason RS (1995) Involvement of platelets in stimulating osteogenic activity. J Orthop Res 13: 655-663.
93. Soffer E, Ouhayoun JP, Anagnostou F (2003) Fibrin sealants and platelet preparations in bone and periodontal healing. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 521-528.
94. Sokolova V, Ludwig AK, Hornung S, Rotan O, Horn PA, Epple M, Giebel B (2011) Characterisation of exosomes derived from human cells by nanoparticle tracking analysis and scanning electron microscopy. Colloids Surf B Biointerfaces 87: 146-150.
95. Sugimori E, Shintani S, Ishikawa K, Hamakawa H (2006) Effects of apatite foam combined with platelet-rich plasma on regeneration of bone defects. Dent Mater J 25: 591-596.
96. Théry C, Amigorena S, Raposo G, Clayton A (2006) Isolation and characterization of exosomes from cell culture supernatants and biological fluids. Curr Protoc Cell Biol 3: Unit 3.22.
97. Théry C, Regnault A, Garin J, Wolfers J, Zitvogel L, Ricciardi-Castagnoli P, Raposo G, Amigorena S (1999) Molecular characterization of dendritic cell-derived exosomes. Selective accumulation of the heat shock protein hsc73. and function. J Cell Biol 147: 599-610.
98. Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2: 569-579.
99. Tomasoni S, Longaretti L, Rota C, Morigi M, Conti S, Gotti E, Capelli C, Introna M, Remuzzi G, Benigni A (2013) Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cell Dev 22: 772-778.
100. Trompeter HI, Dreesen J, Hermann E, Iwaniuk KM, Hafner M, Renwick N, Tuschl T, Wernet P (2013) MicroRNAs miR-26a, miR-26b, and miR-29b accelerate osteogenic differentiation of unrestricted somatic stem cells from human cord blood. BMC Genomics 14: 111.
101. Urbanelli L, Magini A, Buratta S, Brozzi A, Sagini K, Polchi A, Tancini B, Emiliani C (2013) Signaling pathways in exosomes biogenesis, secretion and fate. Genes 4: 152- 170.
102. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ, Lotvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9: 654-659.
103. Van Bergen CJ, Kerkhoffs GM, Ozdemir M, Korstjens CM, Everts V, van Ruijven LJ, van Dijk CN, Blankevoort L (2013) Demineralized bone matrix and platelet-rich plasma do not improve healing of osteochondral defects of the talus: an experimental goat study. Osteoarthritis Cartilage 21: 1746-1754.
104. Von Schwedler UK, Stuchell M, Muller B, Ward DM, Chung HY, Morita E, Wang HE Davis T, He GP, Cimbora DM, Scott A, Kräusslich HG, Kaplan J, Morham SG, Sundquist WI (2003) The protein network of HIV budding. Cell 144: 701-713.
105. Waldenström A, Gennebäck N, Hellman U, Ronquist G (2012) Cardiomyocyte microvescicles contain DNA/RNA and convey biological messages to target cells. PLoS One 7: e34653.
106. Wang GJ, liu Y, Qin A, Shah SV, Deng ZB, Xiang X, Cheng Z, Liu C, Wang J, Zhang J, Zhang L, Grizzle WE, Zhang HG (2008) Thymus exosomes-like particles induce regulatory T cells. J Immunol 181: 5242-5248.
107. Warnke PH, Humpe A, Strunk D, Stephens S, Warnke F, Wiltfang J, Schallmoser K, Alamein M, Bourke R, Heiner P, Liu Q (2013) A clinically-feasible protocol for using human platelet lysate and mesenchymal stem cells in regenerative therapies. J Craniomaxillofac Surg 41: 153-161.
108. Yang X, Meng S, Jiang H, Zhu C, Wu W (2011) Exosomes derived from immature bone marrow dendritic cells induce tolerogenicity of intestinal transplantation in rats. J Surg Res 171: 826-832.
109. Zhang BG, Li JF, Yu BQ, Zhu ZG, Liu BY, Yan M (2012) microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN. Oncol Rep 27: 1019-1026.
110. Zhang HC, Liu XB, Huang S, Bi XY, Wang HX, Xie LX, Wang YQ, Cao XF, Lv J, Xiao FJ, Yang Y, Guo ZK (2012) Microvesicles derived from human umbilical cord mesenchymal stem cells stimulated by hypoxia promote angiogenesis both in vitro and in vivo. Stem Cells Dev 21: 3289-3297.
111. Zhang HG, Liu C, Su K, Yu S, Zhang L, Zhang S, Wang J, Cao X, Grizzle W, Kimberly RP (2006) A membrane form of TNF-{alpha} presented by exosomes delays T cell activation induced cell death. J Immunol 176: 7385-7893.
112. Zhao B, Han H, Chen J, Zhang Z, Li S, Fang F, Zheng Q, Ma Y, Zhang J, Wu N, Yang Y (2014) MicroRNA let-7c inhibits migration and invasion of human non-small cell lung cancer by targeting ITGB3 and MAP4K3. Cancer Lett 342: 43-51.
113. Zhu Y, Yuan M, Meng HY, Wang AY, Guo QY, Wang Y, Peng Y (2013) Basic science and clinical application of platelet-rich plasma for cartilage defects and osteoarthritis: a review. Osteoarthritis Cartilage 21: 1627-1637
114. Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ (2011) Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 29: 341-345.
115. Camacho L, Guerrero P, Marchetti D (2013) MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PLoS One 8: e73790.
116. Dai S, Wei D, Wu Z, Zhou X, Wei X, Huang H, Li G (2008) Phase I clinical trial of autologous ascites-derived exosomes combined with gm-csf for colorectal cancer. Mol Ther 16: 782-790.
117. Escudier B, Dorval T, Chaput N, André F, Caby MP, Novault S, Flament C, Leboulaire C, Borg C, Amigorena S, Boccaccio C, Bonnerot C, Dhellin O, Movassagh M, Piperno S, Robert C, Serra V, Valente N, Le Pecq JB, Spatz A, Lantz O, Tursz T, Angevin E, Zitvogel L (2005) Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of the first phase I clinical trial. J Transl Med 3: 10.
118. Lai RC, Yeo RW, Tan KH, Lim SK (2013) Exosomes for drug delivery - a novel application for the mesenchymal stem cell. Biotechnol Adv 31: 543-551.
119. Morse MA, Garst J, Osada T, Khan S, Hobeika A, Clay TM, Valente N, Shreeniwas R, Sutton MA, Delcayre A, Hsu DH, Le Pecq JB, Lyerly HK (2005) A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer. J Transl Med 3: 9.
120. Riches A, Campbell E, Borger E, Powis S (2014) Regulation of exosome release from mammary epithelial and breast cancer cells - a new regulatory pathway. Eur J Cancer 50: 1025-1034.
121. Roccaro AM, Sacco A, Maiso P, Azab AK, Tai YT, Reagan M, Azab F, Flores LM, Campigotto F, Weller E, Anderson KC, Scadden DT, Ghobrial IM (2013) BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression. J Clin Invest 123: 1542- 1555.
122. Sun D, Zhuang X, Xiang X, Liu Y, Zhang S, Liu C, Barnes S, Grizzle W, Miller D, Zhang HG (2010) A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes. Mol Ther 18: 1606-1614.
123. Tian Y, Li S, Song J, Ji T, Zhu M, Anderson GJ, Wei J, Nie G (2014) A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials 35: 2383-2390.